COLUMBIA, Mo. — Bayer is optimistic that their recent merge with Monsanto will benefit producers and consumers alike as they closed their acquisition on June 7. And Columbia’s mayor, Brian Treece said he is also certain that the merge will be an advantage for communities within Missouri.

Throughout the decades, MU and Monsanto’s partnership has aided university researchers in feeding the world and advancing medical research for people to lead healthy lives.

“You’ve got the great work of the animal science division of Bayer,” Treece said. “Everyone’s familiar with the plant science division at Monsanto. But here in Columbia, Missouri, those two come together at the University of Missouri where every day we’re presenting and inventing new cutting edge products, soybean patents and lifesaving cures that really benefit all Missourians.”

After speaking to leaders at Bayer, Treece said the company assured him they are committed to strengthening already established collaborations between Monsanto and organizations throughout the United States. He said it was part of their “corporate ethos” to further grow the relationship between MU and now-Bayer.

“Where Bayer and Monsanto come together in my community is at the Missouri Innovation Center at Monsanto Place,” Treece said. “Of course we’ve got a number of scientists, researchers and developers that are already working on cutting edge products. But as I’ve had the opportunity to tour Bayer and Monsanto executives in Columbia, Missouri, the number of people that have an impact with that company, including the U.S. Geological Service that are looking at fish and wildlife protections, all benefit from the great work of animal science, plant science and life sciences that are possible now under this partnership.”

The Missouri Innovation Center located at 1601 S. Providence Road in Columbia, is a non-profit organization geared toward providing assistance with business ventures that can help “improve human life and sustainability.” In addition to the Missouri Innovation Center, Treece explained the university is developing another beneficial entity that is strengthened by the MU and Bayer partnership.

“One of the things that the University of Missouri is developing is the Translational Precision Medicine Complex that really combines the multidisciplinary efforts of veterinary medicine, nuclear medicine, our School of Medicine and teaching hospital, along with our agriculture department and engineering department to really develop these types of integrated cures that benefit everybody,” Treece said.

The mayor said he believes the merger will yield better results and add to the list of positive impacts for Missourians in all communities.

Calls to the MU News Bureau for further comment have not been returned.